Hopp til innhold
NHI.no
Annonse

Munnsvelgkreft (orofarynkskreft): Symptomer

Innhold i artikkelen

I starten gir denne kreftformen svært få symptomer. Sykdommen kan derfor være vanskelig å oppdage. Det første man gjerne oppdager, er kuler på halsen og sår hals (ensidig). Andre symptomer og tegn kan blant annet være svelgproblemer, smerter i øre, fremmedlegemefølelse i halsen, sår som ikke gror eller en synlig kul i orofarynks. Etter hvert kan man merke økende smerter og blødninger fra sår på svulsten. Dessverre har sykdommen vart en stund når disse symptomene kommer, og det er risiko for at kreften har rukket å spre seg.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Orofarynkskreft . Referanselisten for dette dokumentet vises nedenfor

  1. Helsedirektoratet. Hode-/halskreft – handlingsprogram [nettdokument]. Oslo: Helsedirektoratet (siste faglige endring 20. oktober 2025, lest 26. november 2025) www.helsedirektoratet.no
  2. Cancer Registry of Norway. Norwegian Institute of Public Health. Cancer in Norway 2024 - Cancer incidence,mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway, 2025. fhi.no
  3. Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022 May;19(5):306-327. PMID: 35105976 PubMed
  4. Nguyen NP, Nguyen LM, Thomas S, et al. Oral sex and oropharyngeal cancer: The role of the primary care physicians. Medicine (Baltimore). 2016 Jul;95(28):e4228. doi: 10.1097/MD.0000000000004228. PMID: 27428229 PubMed
  5. McKenna D, Mayne R, Carson C, Collins S, Reddy E. HPV positive oropharyngeal cancer. BMJ. 2025 Oct 9;391:e086142. PMID: 41067787 PubMed
  6. Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck 2013;35:747–55. PMID: 22267298 PubMed
  7. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012;48:1191–201. PMID: 22841677 PubMed
  8. Dahlstrand H, Näsman A, Romanitan M, Lindquist D, Ramqvist T, Dalianis T. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008; 28: 1133-8. PubMed
  9. Nichols AC, Theurer J, Prisman E, et al. Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial. J Clin Oncol. 2024 Dec;42(34):4023-4028. PMID: 3930318 PubMed
  10. Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008; 26: 3138-46. PubMed
  11. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35. PMID: 20530316 PubMed
  12. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9. PubMed
  13. Cramer JD, Grauer J, Sukari A et al. Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021 Oct 28. Epub ahead of print. PMID: 34709369 PubMed
Annonse
Annonse